Ebola Vaccine Trials Will Start in Weeks, Say WHO and Company

October 6, 2014

(CBC) – Clinical trials of an experimental Ebola vaccine developed in Canada will start within weeks, confirm officials with the company licensed to commercialize it as well as the World Health Organization. This comes just days after scientists around the world raised concerns safety tests were being needlessly delayed because of intellectual property concerns.? “Treatment of the first patients in clinical trials is imminent at both the [U.S.] Department of Defence and the National Institute of Allergy and Infectious Disease,” Brian Wiley, vice-president of business development at NewLink Genetics, stated in an email to CBC News on Friday.